Gamco Investors INC. ET AL reduced its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 10.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,825 shares of the medical instruments supplier’s stock after selling 4,250 shares during the period. Gamco Investors INC. ET AL owned approximately 0.17% of ICU Medical worth $9,847,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ICUI. First Trust Advisors LP lifted its stake in shares of ICU Medical by 436.0% in the 3rd quarter. First Trust Advisors LP now owns 108,440 shares of the medical instruments supplier’s stock valued at $30,661,000 after purchasing an additional 88,207 shares in the last quarter. OppenheimerFunds Inc. lifted its stake in shares of ICU Medical by 58.1% in the 2nd quarter. OppenheimerFunds Inc. now owns 225,807 shares of the medical instruments supplier’s stock valued at $66,308,000 after purchasing an additional 82,976 shares in the last quarter. Federated Investors Inc. PA lifted its stake in shares of ICU Medical by 623.9% in the 2nd quarter. Federated Investors Inc. PA now owns 86,204 shares of the medical instruments supplier’s stock valued at $25,314,000 after purchasing an additional 74,296 shares in the last quarter. Cornerstone Wealth Management LLC acquired a new position in shares of ICU Medical in the 2nd quarter valued at about $237,000. Finally, Wells Fargo & Company MN lifted its stake in shares of ICU Medical by 15.6% in the 3rd quarter. Wells Fargo & Company MN now owns 507,855 shares of the medical instruments supplier’s stock valued at $143,595,000 after purchasing an additional 68,347 shares in the last quarter. 73.51% of the stock is currently owned by institutional investors and hedge funds.
In other ICU Medical news, Director Pfizer Inc sold 700,000 shares of the company’s stock in a transaction that occurred on Monday, August 13th. The stock was sold at an average price of $284.35, for a total value of $199,045,000.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Virginia Ruth Sanzone sold 787 shares of the company’s stock in a transaction that occurred on Tuesday, August 28th. The shares were sold at an average price of $303.12, for a total value of $238,555.44. Following the completion of the transaction, the vice president now directly owns 1,367 shares in the company, valued at $414,365.04. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 711,920 shares of company stock worth $202,651,956. 12.50% of the stock is currently owned by corporate insiders.
Several equities analysts have recently weighed in on ICUI shares. TheStreet raised ICU Medical from a “c+” rating to a “b+” rating in a research note on Monday, August 20th. ValuEngine lowered ICU Medical from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 3rd. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, September 28th. Finally, Zacks Investment Research lowered ICU Medical from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 11th.
Shares of ICUI opened at $232.01 on Friday. ICU Medical, Incorporated has a 52-week low of $196.33 and a 52-week high of $321.70. The company has a market capitalization of $5.31 billion, a price-to-earnings ratio of 35.99 and a beta of 0.65.
ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, November 8th. The medical instruments supplier reported $1.85 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.51 by $0.34. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. The company had revenue of $327.20 million for the quarter, compared to analyst estimates of $334.97 million. During the same period in the prior year, the company posted $1.12 EPS. ICU Medical’s quarterly revenue was down 4.7% on a year-over-year basis. Equities research analysts anticipate that ICU Medical, Incorporated will post 7.6 earnings per share for the current year.
ICU Medical Company Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Further Reading: Swap
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.